Brief: HeartBeam Reports Fourth Quarter And Full Year 2022 Financial Results
16/03/2023 22:39
March 16 (Reuters) - HeartBeam Inc BEAT.O :
* HEARTBEAM REPORTS FOURTH QUARTER AND FULL YEAR 2022
FINANCIAL
RESULTS
* HEARTBEAM INC - INITIAL FDA SUBMISSION OF HEARTBEAM
AIMIGO™,
TELEHEALTH SOLUTION, PROJECTED FOR Q2 2023
Source text for Eikon: ID:nBw9hDjSta
Further company coverage: BEAT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on HeartBeam
See all newsBrief: Heartbeam Receives FDA Breakthrough Device Designation For Heart Attack Assessment
Brief: HeartBeam Will Not Build Large Commercial Organization For Arrhythmia Indication
Brief: Heartbeam, Inc. Enters Into At-The-Market Equity Offering Sales Agreement For Up To $25 Million In Common Stock
HeartBeam, Inc. reports results for the quarter ended June 30 - Earnings Summary
HeartBeam Q2 loss per share narrows; co lowers FY net operating cash outflow guidance